Skip to content
About Us
History
Leadership
Scientific Advisory Board
Collaboration and Partnership
Locations
Our Science
Small Molecules
ADC Platform
Pipeline
Small Molecules
Kinases
Encorafenib (BRAF)
Entrectinib (TRK, ROS)
Onvansertib (PLK1)
NMS-153 (MPS1)
NMS-812 (PERK/ GCN2)
Early Pipeline Projects
NAD+ Binding Family: PARP
NMS-293 (PARP1)
Atamparib (PARP7)
ADC Platform
Peptide Drug Conjugate (PDC)
Antibody Drug Conjugate (ADC)
Platform of Payload- Linkers
News/Events & Publications
News
Events
Publications
Careers
Contact Us
About Us
History
Leadership
Scientific Advisory Board
Collaboration and Partnership
Locations
Our Science
Small Molecules
ADC Platform
Pipeline
Small Molecules
Kinases
Encorafenib (BRAF)
Entrectinib (TRK, ROS)
Onvansertib (PLK1)
NMS-153 (MPS1)
NMS-812 (PERK/ GCN2)
Early Pipeline Projects
NAD+ Binding Family: PARP
NMS-293 (PARP1)
Atamparib (PARP7)
ADC Platform
Peptide Drug Conjugate (PDC)
Antibody Drug Conjugate (ADC)
Platform of Payload- Linkers
News/Events & Publications
News
Events
Publications
Careers
Contact Us
Search
15th International Conference on Malignant Lymphoma
Home
/
News/Events & Publications
/ 15th International Conference on Malignant Lymphoma
June 18–22
Lugano, Switzerland
15th International Conference on Malignant Lymphoma
25 years of DNA Encoded Chemistry: managing serendipity in pre-clinical small molecule drug discovery?” Barry Morgan
16th Annual Meeting of the Bioinformatics Italian Society
Share this page
Facebook
Twitter
LinkedIn
Email
svg.e-font-icon-svg {display:none!important} .elementor-button-icon {display:none!important} .show-more, .show-more2 {display:none!important}